
Glimepiride 2 mg, Metformin Hydrochloride (SR) 500 mg & Voglibose 0.2 mg Tablets
| Composition | Glimepiride 2 mg, Metformin Hydrochloride (SR) 500 mg & Voglibose 0.2 mg Tablets |
|---|---|
| Dosage form | Tablet (Modified Release) |
| Specification | In-house |
| Therapeutic category | Cardiovascular & Metabolic Care |
| Shelf life | 24 months |
| Pack | Alu PVC (10X15) |
| Dossier | CTD / eCTD / ACTD dossier compilation provided on request |
| Registrations | Available on request |
Finecure Pharmaceuticals delivers trusted, innovation-led healthcare
brands
designed to meet global
standards
of
quality and efficacy.